featured
C-Peptide and Metabolic Outcomes in Trials of Disease-Modifying Therapy in Patients With New-Onset Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis
Lancet Diabetes Endocrinol 2023 Nov 03;[EPub Ahead of Print], PN Taylor, KS Collins, A Lam, SR Karpen, B Greeno, F Walker, A Lozano, E Atabakhsh, ST Ahmed, M Marinac, E Latres, PA Senior, M Rigby, PA Gottlieb, CM DayanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.